中藥調(diào)控P53治療糖尿病腎病的研究進展

Research Progress on the Regulation of P53 by Traditional Chinese Medicine in the Treatment of Diabetic Nephropathy

JIN Rui1，ZHOUFu-rong1，BAO Yun2

（1.InnerMongolia Medical University，HohhotO1ooio，China; 2.TheAffiliated Hospital of InnerMongoliaMedical University，Hohhot Oiooio，China）

【Abstract】Diabetic kidney disease （DKD） is one of the common and serious microvascular complications of diabetes and has become a major factor in end -stage renal diseases worldwide.Currently，the number of DKD patients worldwide accounts for 8%-10% of the total world population. It is estimated that this number will increase to 592 millon by2O35.The incidencerateof DKDinChina isalso gradually increasing.Due to the complex pathogenesis of DKD，it alsoadds many dificulties to clinical treatment.P53，as an important tumorsuppressor gene，has been confirmed to playa significant role in the occurrence and development of diabetic nephropathy.In recent years，an increasing number of studies have focusedon the treatment of diabetic nephropathy by traditional Chinese medicine through regulating P53，achieving remarkable results.By systematically sorting out and summarizing the latest research progress in this field，new ideas and strategies are provided for the treatment of diabetic nephropathy.

【Key words】Chinese Herbal Medicine；P53； Diabetic nephropathy； Mechanism；Research Progress

糖尿病腎病（diabetickidneydisease，DKD）是糖尿病常見的微血管并發(fā)癥，主要與體內(nèi)長期的高糖環(huán)境導(dǎo)致的腎臟結(jié)構(gòu)和功能損害有關(guān)，主要臨床表現(xiàn)為持續(xù)性蛋白尿及腎功能進行性下降[1]。（剩余16889字）